376 related articles for article (PubMed ID: 18250636)
1. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
3. Metformin in polycystic ovary syndrome.
Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
[TBL] [Abstract][Full Text] [Related]
4. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and the metabolic syndrome.
Weerakiet S
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and polycystic ovary syndrome.
Galluzzo A; Amato MC; Giordano C
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
Lakhani K; Prelevic GM; Seifalian AM; Atiomo WU; Hardiman P
J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
[TBL] [Abstract][Full Text] [Related]
12. Use of insulin sensitizers in polycystic ovarian syndrome.
Baillargeon JP
Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
[TBL] [Abstract][Full Text] [Related]
13. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
Tomlinson J; Millward A; Stenhouse E; Pinkney J
Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
[TBL] [Abstract][Full Text] [Related]
15. Current perspectives of insulin resistance and polycystic ovary syndrome.
Pauli JM; Raja-Khan N; Wu X; Legro RS
Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome in polycystic ovary syndrome.
Essah PA; Wickham EP; Nestler JE
Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
[TBL] [Abstract][Full Text] [Related]
17. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.
Tasali E; Van Cauter E; Hoffman L; Ehrmann DA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3878-84. PubMed ID: 18647805
[TBL] [Abstract][Full Text] [Related]
18. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
Pasquali R; Gambineri A
Expert Opin Ther Targets; 2009 Oct; 13(10):1205-26. PubMed ID: 19650762
[TBL] [Abstract][Full Text] [Related]
19. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
Sharma ST; Nestler JE
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk in women with polycystic ovary syndrome.
Cho LW; Atkin SL
Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
